James Flynn
Net worth: 181 800 $ as of 30/09/2026
Net worth: 181 800 $ as of 30/09/2026
Mr. James Flynn, CFA, is an Independent Director at RiceBran Technologies, an Independent Non-Executive Director at Lite Strategy, Inc. and a Managing Member & Portfolio Manager at Nerium Capital LLC.
He is on the Board of Directors at Synlogic, Inc., RiceBran Technologies, Lite Strategy, Inc. and Axiom Healthcare Strategies LLC.
Mr. Flynn was previously employed as an Independent Director by ARCA biopharma, Inc. and a Manager-Healthcare Portfolio by Amici Capital LLC.
He also served on the board at Axiom Health, Inc. He received his undergraduate degree from Massachusetts Institute of Technology.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LITE STRATEGY INC 0.41% | 22/09/2026 | 1,25,000 ( 0.41% ) | 165 000 $ | 30/09/2026 |
SYNLOGIC INC 0.12% | 31/03/2026 | 15,000 ( 0.12% ) | 16 800 $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| LITE STRATEGY, INC. | Director/Board Member | 31/10/2023 |
| RICEBRAN TECHNOLOGIES | Director/Board Member | 03/01/2024 |
| SYNLOGIC, INC. | Director/Board Member | 19/03/2024 |
Axiom Healthcare Strategies LLC
Axiom Healthcare Strategies LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Board Member | 01/07/2022 |
Nerium Capital LLC | Founder | 01/01/2021 |
| Companies | Position | End |
|---|---|---|
Amici Capital LLC
Amici Capital LLC Investment ManagersFinance Amici Capital invests in equities both long and short. They practice a flexible, value-oriented approach that encompasses investments in the publicly traded securities of companies in a broad spectrum of industries and geographies. The firm seeks to have a core long-term, large investment in relatively few stocks on the long side, taking advantage of in-depth knowledge of favored companies, with a complement on the short side that represents both significant profit opportunities and a market hedge. Amici Capital seeks to achieve strong absolute returns in all market environments, with a concurrent focus on capital preservation. | Corporate Officer/Principal | 01/01/2017 |
| ARCA BIOPHARMA | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Amici Capital LLC
Amici Capital LLC Investment ManagersFinance Amici Capital invests in equities both long and short. They practice a flexible, value-oriented approach that encompasses investments in the publicly traded securities of companies in a broad spectrum of industries and geographies. The firm seeks to have a core long-term, large investment in relatively few stocks on the long side, taking advantage of in-depth knowledge of favored companies, with a complement on the short side that represents both significant profit opportunities and a market hedge. Amici Capital seeks to achieve strong absolute returns in all market environments, with a concurrent focus on capital preservation. | Finance |
RiceBran Technologies
RiceBran Technologies Agricultural Commodities/MillingProcess Industries Engages in rice milling for producing, processing and marketing of natural and nutrient dense products derived from grains | Process Industries |
MEI Pharma, Inc.
MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
ARCA biopharma, Inc.
ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Synlogic, Inc.
Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Nerium Capital LLC | |
Axiom Healthcare Strategies LLC
Axiom Healthcare Strategies LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Select your edition
All financial news and data tailored to specific country editions